Horton Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $6.7M | Buy |
704,749
+20,000
| +3% | +$190K | 14.94% | 2 |
|
|
2021
Q3 | $11.5M | Buy |
684,749
+56,674
| +9% | +$953K | 23.27% | 2 |
|
|
2021
Q2 | $9.59M | Buy |
628,075
+8,800
| +1% | +$134K | 13.04% | 2 |
|
|
2021
Q1 | $12.1M | Buy |
619,275
+228,847
| +59% | +$4.46M | 20.67% | 2 |
|
|
2020
Q4 | $7.04M | Buy |
390,428
+15,000
| +4% | +$270K | 8.12% | 2 |
|
|
2020
Q3 | $7.24M | Sell |
375,428
-8,000
| -2% | -$154K | 6.96% | 2 |
|
|
2020
Q2 | $10M | Buy |
383,428
+131,809
| +52% | +$3.44M | 7.55% | 2 |
|
|
2020
Q1 | $4.49M | Buy |
251,619
+142,949
| +132% | +$2.55M | 4.25% | 3 |
|
|
2019
Q4 | $3.63M | Buy |
+108,670
| New | +$3.63M | 3.53% | 3 |
|